Intrinsic Value of S&P & Nasdaq Contact Us

Harpoon Therapeutics, Inc. HARP

NASDAQ Global Select

SharesGrow Score
46/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$700.00
+2942.2%

Harpoon Therapeutics, Inc. (HARP) current share price is $23.01. The gold spot price is $4,808.10 per troy ounce. Using the formula: HARP in gold = $23.01 × 31.1035 ÷ $4,808.10 = 0.1489 grams of gold per share.

The Real Wealth Growth Rate measures the Compound Annual Growth Rate (CAGR) of HARP when denominated in gold. A positive rate means the stock has outperformed gold as a store of value, while a negative rate indicates gold has been a better wealth preserver than holding HARP shares over the measured period.

HARP in US Dollars
Gold in US Dollars
HARP in Gold (grams per share)

Real Wealth Growth Rate

HARP
Computing…

"Real Wealth Growth Rate" measures the annualised compound growth rate (CAGR) of a stock when priced in gold — hard money that cannot be printed. A positive value means genuine wealth creation. A negative value means purchasing power is shrinking, even if the dollar price rises.

Step 1 — Express share price in grams of gold
$$\text{HARP}_{\text{gold}}(t) = \frac{P_{\text{HARP}}(t) \times 31.1035}{P_{\text{gold}}(t)}$$
$P_\text{HARP}$ = stock price in USD, $P_\text{gold}$ = gold spot in USD/troy oz, $31.1035$ = grams per troy ounce.
Step 2 — Real Wealth Growth Rate (CAGR in gold terms)
$$\text{Real Wealth Growth Rate} = \left(\frac{\text{HARP}_{\text{gold}}^{(T)}}{\text{HARP}_{\text{gold}}^{(0)}}\right)^{\!\frac{1}{T}} - 1$$
$\text{HARP}_\text{gold}^{(0)}$ = initial gold-price, $\text{HARP}_\text{gold}^{(T)}$ = current gold-price, $T$ = number of years. A positive result means the stock outpaces gold.

Real Wealth Growth Rate Rankings — 20 Years

Computing…

People Also View

RVMD
RVMD
Revolution Medicines, Inc.
$147.01
+7.86%
STOK
STOK
Stoke Therapeutics, Inc.
$35.86
+2.31%
ALEC
ALEC
Alector, Inc.
$2.41
+3.43%
BDTX
BDTX
Black Diamond Therapeutics, Inc.
$2.66
-2.21%
ADAP
ADAP
Adaptimmune Therapeutics plc
$0.05
-3.00%
TCRR
TCRR
TCR2 Therapeutics Inc.
$1.48
+0.00%
PASG
PASG
Passage Bio, Inc.
$10.86
+0.46%
BCEL
BCEL
Atreca, Inc.
$0.09
-1.32%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message